HIV News and Research

RSS

New study shows response to HIV vaccine in 6 weeks

A new study using DNA-based and protein HIV vaccines in various combinations shows that antibody and cellular immune response occurs within 6 weeks from the date of vaccination, and the combination must be administered together for the most rapid protection. This will enable more large-scale testing of the vaccine for effectiveness. About 40 million people today have HIV infections, and 1.2 million deaths a year are related to this infection.

1 Oct 2019

Interprofessional collaboration may help improve patients' access to HIV testing and primary care

Getting better access to testing and proper primary care for individuals vulnerable to HIV could be as simple as a telephone call or email among health providers.

1 Oct 2019

Domestic violence may affect mothers' breastfeeding practices in developing countries

Mothers who have suffered from domestic violence are substantially less likely to follow recommended breastfeeding practices in low to middle-income countries, a new study shows.

1 Oct 2019

US Government to fund development of a 'universal flu vaccine'

The US government is to provide up to 400 million USD in funding to develop a “universal” flu vaccination at Duke University over the next seven years.

1 Oct 2019

Infectious disease experts explain how to stay healthy during the flu season

About 40 million people contracted the flu last year, with hundreds of thousands hospitalized and 35,400 to 61,000 deaths, including 134 children, according to the Centers for Disease Control and Prevention.

30 Sep 2019

Duke Human Vaccine Institute participates in a large national effort to improve flu shots

As part of a massive national effort to improve and modernize flu shots, the Duke Human Vaccine Institute has received three research contracts from the National Institute of Allergy and Infectious Diseases, with an initial award of approximately $29.6 million in first-year funding.

30 Sep 2019

Limited research on prevention of sexual violence against women in sub-Saharan Africa

Sexual violence is a human rights issue and a women's health issue. Without adequate research-based knowledge, neither health services nor the justice system can offer victims the help they need.

27 Sep 2019

NIH awards $30 million to accelerate progress in TB vaccine development

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded $30 million in first-year funding to establish new centers for immunology research to accelerate progress in tuberculosis vaccine development.

26 Sep 2019

Researcher aims to make CRISPR-Cas9 system safer and more precise

The mere mention of gene editing and DNA altering might conjure up images of designer babies, but that is not what researcher Jin Liu has in mind.

26 Sep 2019

Healthcare records hacked, data breaches uncovered

Researcher John (Xuefeng) Jiang shows that the health records of almost 170 million people over the country have been hacked in 1461 reported data breaches. These occurred over a period of ten years, from October 21, 2009, to July 1, 2019.

25 Sep 2019

Dormant HIV reservoirs could be killed with RNA switch

Researchers from the University of California San Diego School of Medicine have found cellular triggers within the immune cells that could be controlled in order to kill dormant HIV-1 reservoirs in individuals with HIV-1.

25 Sep 2019

$22 million NIH grant helps renew AIDS and Cancer Specimen Resource

The AIDS and Cancer Specimen Resource has been renewed with the George Washington University serving as the primary site for the next five years, through a $22 million grant from the National Institutes of Health.

25 Sep 2019

Researchers identify key switch that eliminates dormant HIV reservoirs

Using genetic sequencing, University of California San Diego School of Medicine researchers have identified a principal cellular player controlling HIV reproduction in immune cells which, when turned off or deleted, eliminates dormant HIV reservoirs.

24 Sep 2019

Wistar awarded more than $12 million to study opioid use in HIV-infected people

The Wistar Institute was awarded two major grants totaling more than $12 million from the National Institute on Drug Abuse, part of the National Institutes of Health, to fund an international multidisciplinary clinical research consortium spearheaded by Wistar's HIV Research Program.

24 Sep 2019

New research uncovers specific data leaked through hospital breaches

When hospitals are hacked, the public hears about the number of victims – but not what information the cybercriminals stole.

24 Sep 2019

New drug delivery system could be a boon for those on a multi-drug regimen

Researchers from the University of North Carolina at Chapel Hill have developed a unique new multi-drug delivery system that could p-rove to be useful for persons who need to take several drugs in a day as part of a regimen.

23 Sep 2019

Advancing towards 100% effective herpes vaccine

Genital herpes, caused by the herpes simplex virus 2 (HSV-2) is a very common sexually transmitted infection (STI). It affects 14% of Americans aged 15-49 years. There is no herpes vaccine at present. Many failed attempts at vaccine production have centered around HSV proteins.

23 Sep 2019

Fullerene compounds effectively combat dangerous viral infections

Scientists from the Skoltech Center for Energy Science and Technology and the Institute of Problems of Chemical Physics of RAS in collaboration with researchers from four other Russian and foreign research centers have discovered a new reaction that helps obtain water-soluble fullerene derivatives which effectively combat flu viruses, human immunodeficiency virus, herpes simplex virus, and cytomegalovirus.

23 Sep 2019

IDSA calls for meaningful funding to control current Ebola outbreak

Spending bills released by Senate Appropriations Committee Wednesday demonstrate encouraging recognition of some of the most urgent health challenges threatening individual and public health at home and abroad.

23 Sep 2019

African bacterium resists almost all drugs

It looks like it’s time to pay the piper. The first extensively drug-resistant (XDR) strain of Salmonella typhimurium, called ST313 sublineage II.1, has cropped up in the Democratic Republic of Congo (DRC). This fails to respond to any of the antibiotics that are commonly used in the DRC, except for ciprofloxacin. And to make things worse, one sample has been isolated that shows incomplete response even to this last drug.

22 Sep 2019